-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Kyverna Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2023 to Q4 2024.
- Kyverna Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $3.66M, a 192% increase year-over-year.
- Kyverna Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $8.36M, a 276% increase year-over-year.
- Kyverna Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $8.36M, a 276% increase from 2023.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)